New York-based Formation Bio, an AI-native pharma company focused on accelerating drug development, revealed that its ...

Formation Bio’s subsidiary, Libertas Bio, has licensed gusacitinib, an oral dual JAK/SYK inhibitor, to Sanofi.

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.

Having secured one of last year’s largest funding rounds, AI-focused Formation Bio is now eyeing up 545 million euros ($626 ...

Researchers at the universities of Amsterdam and Utrecht have observed the formation of nanocavities in montmorillonite clay ...

The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...

(The Center Square) – Shortly before the Iranian attack on a U.S. military base, a Georgetown professor posted that he hoped ...

Researchers at the universities of Amsterdam and Utrecht have observed the formation of nanocavities in montmorillonite clay under exposure to ...

EA Sports unveiled several new features coming to College Football 26. Here's a look at new pregame rituals, mascots and Dynasty and Team Builder modes.

Sierra Leone's President Julius Maada Bio has been elected as the new Chairman of the ECOWAS Authority of Heads of State and ...

Sierra Leone’s President Julius Maada Bio has been elected Chairman of the ECOWAS Authority of Heads of State and Government, ...